Search Login Register

Prolactinoma (Prolactinomas) Summary

1552 relevant articles (110 outcomes, 137 trials/studies) found for this Disease

Description: A pituitary adenoma which secretes PROLACTIN, leading to HYPERPROLACTINEMIA. Clinical manifestations include AMENORRHEA; GALACTORRHEA; IMPOTENCE; HEADACHE; visual disturbances; and CEREBROSPINAL FLUID RHINORRHEA.

Also Known As: Prolactinomas; Lactotroph Adenoma; Macroprolactinoma; Microprolactinoma; Prolactin-Producing Pituitary Adenoma Show All >>

Key Drugs and Agents for Prolactinoma

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Bromocriptine (Parlodel) : 32 outcomes 34 studies in 429 results : FDA 5 Generic
  2. Dopamine Agonists (Dopamine Agonist) : 27 outcomes 10 studies in 214 results : IBA
  3. Prolactin : 24 outcomes 31 studies in 508 results : IBA
  4. cabergoline : 15 outcomes 8 studies in 78 results : FDA 4 Generic
  5. quinagolide : 12 outcomes 8 studies in 39 results : IBA
  6. Dopamine (Intropin) : 5 outcomes 6 studies in 81 results : FDA 36 Generic
  7. Adrenocorticotropic Hormone (ACTH) : 5 outcomes 2 studies in 95 results : FDA 6
  8. Hormones : 4 outcomes 6 studies in 106 results : IBA
  9. Somatostatin (Somatotropin Release-Inhibiting Factor) : 4 outcomes 5 studies in 26 results : IBA
  10. Growth Hormone (Somatotropin) : 2 outcomes 8 studies in 125 results : IBA
Show All >>

Diseases Related to Prolactinoma

  1. Neoplasms (Cancer)
  2. Prolactinoma (Prolactinomas)
  3. Adenoma (Adenomas)
  4. Acromegaly
  5. Pituitary Neoplasms (Pituitary Adenoma)
Show All >>

Key Therapies for Prolactinoma

Efficacy Chart >>
  1. Drug Therapy (Chemotherapy) : 2 outcomes in 14 results
  2. Aftercare (After-Treatment) : 1 outcome 2 studies in 14 results
  3. Pituitary Irradiation : 1 outcome in 7 results
  4. Craniotomy : 1 outcome in 3 results
  5. Hypophysectomy : 1 study in 12 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.